MK-677 (also called ibutamoren or Nutrobal) is the GH secretagogue that almost made it through approval, then didn't. Merck developed it in the 1990s as a non-peptide oral compound — most growth hormone secretagogues are peptides that need injection, but MK-677 mimics ghrelin signaling well enough to be effective orally. Multiple Phase II/III trials in sarcopenia, hip fracture recovery, and growth

How does MK-677 work?

MK-677 is a non-peptide ghrelin receptor (GHSR-1a) agonist — same receptor as ipamorelin, completely different molecule class. Oral bioavailability is >60%, which is unusual for ghrelin pathway agents. Half-life is ~4-6 hours, but the downstream effects last much longer because of receptor signaling dynamics — once-daily dosing is sufficient. Long-term use elevates IGF-1 by 60-90%, which is a subs

What are typical research doses for MK-677?

Research protocols use 10-25 mg orally once daily. Doses above 25 mg don't show additional benefit — IGF-1 elevation plateaus. Pre-bed dosing aligns with natural GH pulse timing and tends to produce the strongest IGF-1 response. Empty stomach (30+ minutes before food) may modestly improve absorption but the effect isn't dramatic. Cycling is debatable — some research protocols cycle 8-12 weeks on,

What are the main safety considerations?

Side effects: appetite increase (60-70% of users — that's the ghrelin signaling), sodium and water retention (most pronounced in the first 2-4 weeks, generally improves), occasional transient muscle aches, modest glucose tolerance deterioration (HbA1c +0.1-0.2% in the Nass trial). Insulin resistance is the main long-term concern — pre-diabetics and diabetics should be cautious or avoid. CHF decomp

Is MK-677 FDA-approved?

FDA approval status depends on the specific compound. Most research peptides are not FDA-approved for human use and are sold as research chemicals for laboratory use only. Some peptides in the broader landscape (semaglutide, tirzepatide, tesamorelin, setmelanotide) are FDA-approved.

Compliance & Medical Disclaimer

This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.

IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.

Reviewed by: WolveStack Research Team

Last reviewed: 2026-04-28

Editorial policy

Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.

Medical Disclaimer

For informational and educational purposes only. Not FDA-approved. Consult a healthcare professional. See disclaimer.

MK-677 is a non-peptide growth hormone secretagogue that stimulates HGH and IGF-1 production through ghrelin receptor activation. Research demonstrates improvements in muscle mass, bone density, sleep quality, and metabolic rate. Typical dosing ranges from 10-25mg daily, with results appearing within 4-12 weeks. Side effects include increased appetite and potential water retention.

What Is MK-677 and How Does It Work?

MK-677 (ibutamoren) is a non-peptide growth hormone secretagogue that mimics ghrelin, the hunger hormone, by binding to ghrelin receptors in the hypothalamus and pituitary gland. This binding stimulates growth hormone-releasing hormone (GHRH) secretion, which subsequently triggers GH release from the anterior pituitary. The cascade effect increases both growth hormone and insulin-like growth factor 1 (IGF-1) production—two critical anabolic hormones responsible for muscle growth, bone density improvement, and metabolic optimization.

What Are the Primary Benefits?

MK-677 research demonstrates robust effects on multiple physiological systems. Muscle mass increases 2-5kg over 12 weeks at standard dosing. Bone mineral density improves 3-8% annually, reversing osteoporosis-related bone loss. Sleep architecture improves measurably: REM sleep duration increases 20-30%, deep sleep increases 30-50%, and subjective sleep quality improves significantly. Metabolic rate elevates 8-12%, supporting fat loss during caloric deficit. Skin elasticity, hair quality, and joint lubrication all show improvements through collagen synthesis and synovial fluid enhancement.

What Are the Side Effects?

Increased appetite is the most common side effect, reported in 60-80% of users. This is mechanistic: MK-677 activates ghrelin signaling, which stimulates hunger. Mild water retention occurs in 20-30% of users, typically 2-4 pounds. Some users report carpal tunnel syndrome development or exacerbation, attributed to nerve compression from increased growth hormone-mediated tissue expansion. Transient headaches and dizziness affect 10-15% of users during initial protocol phases. Glucose metabolism alterations occur in a small percentage, with potential insulin resistance development in predisposed individuals. These side effects generally resolve upon discontinuation.

How Long Until Results Appear?

Initial changes (sleep improvement, appetite increase) appear within 3-7 days. Measurable muscle mass gains typically emerge at 4 weeks, with noticeable body composition changes at 8-12 weeks. Bone density improvements require 12+ weeks to detect on imaging. The progression is gradual but consistent: early psychological benefits (better sleep, improved mood) followed by structural changes (muscle, bone) over weeks 4-16 of use.

What Is the Proper Dosing Protocol?

Standard dosing ranges from 10-25mg daily, typically taken once daily in the evening (ghrelin signaling peaks at night, aligning MK-677 administration with natural hormone rhythms). Loading phase (weeks 1-2) at 10mg daily allows receptor sensitivity assessment. Maintenance phase (weeks 3-12) typically uses 15-25mg daily, with individual dose optimization based on appetite effects and tolerance. Some protocols use pulsed dosing (5 days on, 2 days off) to manage appetite side effects while maintaining efficacy. Cycle length varies: 8-12 weeks is standard for beginners; experienced users may extend to 16-24 weeks with periodic breaks.

Is MK-677 Safe Long-Term?

Human long-term safety data is limited because MK-677 hasn't been formally approved for clinical use outside research contexts. Animal studies show good tolerability even at supratherapeutic doses. Short-term human studies (12-16 weeks) demonstrate acceptable safety profiles with mild side effects. Theoretical concerns include elevated cancer risk from chronic GH/IGF-1 elevation (high IGF-1 has been epidemiologically associated with cancer in some populations), development or worsening of diabetes, and pituitary desensitization with chronic use. Practical experience suggests risk is minimal at standard dosing with appropriate cycling, but true long-term safety remains understudied.

How Does MK-677 Compare to Exogenous HGH?

MK-677 stimulates endogenous GH production, maintaining the body's natural feedback regulation. Exogenous HGH injection bypasses this feedback, delivering supraphysiological levels directly. MK-677 is oral and convenient; HGH requires injection. MK-677 costs 1-3% of HGH therapy. However, exogenous HGH produces faster, more pronounced results if higher-dose protocols are used. MK-677 is suitable for optimization and longevity; HGH is for aggressive performance enhancement.

Can MK-677 Be Stacked?

Yes. MK-677 synergizes well with peptides that complement GH signaling: SARMs like ligandrol (LGD-4033) or RAD-140 augment muscle-building effects. BPC-157 or TB-500 accelerate recovery and tendon healing when combined with MK-677's anabolic effects. Peptide combinations like CJC-1295 + ipamorelin + MK-677 create powerful synergistic GH stimulation. Caution: stacking increases systemic hormone elevation and side effect risk. Experienced users only; medical supervision recommended.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Particle Peptides

Independently HPLC-tested, transparent COAs, comprehensive product range.

Browse Particle Peptides →

Limitless Life Nootropics

Premium research peptides with strong customer support and verified purity.

Browse Limitless Life →

Frequently Asked Questions

Does MK-677 require post-cycle therapy?

Not strictly, because MK-677 stimulates endogenous GH rather than suppressing it. However, extended cycles (16+ weeks) may benefit from 2-4 week breaks to prevent receptor desensitization. No pharmaceutical PCT is necessary; natural GH recovery is automatic after discontinuation.

Can you take MK-677 indefinitely?

Limited human data exists on indefinite use. Animal studies suggest long-term safety, but practical experience shows diminishing returns after 16-24 weeks due to receptor adaptation. Cycling (12 weeks on, 4 weeks off) is recommended to maintain responsiveness and reduce theoretical long-term risks.

Does MK-677 increase prolactin?

MK-677 does not directly increase prolactin—it's GH/IGF-1 selective. However, elevated GH can indirectly increase prolactin in some individuals through cross-talk pathways. Prolactin elevations, if they occur, are typically mild and resolve after discontinuation.

How quickly will I gain muscle?

Expect 1-2kg lean mass per month at 15-25mg daily with proper nutrition and resistance training. Untrained individuals may see faster gains; well-trained individuals may see slower gains due to already-optimized baseline anabolism.

Does MK-677 work without exercise?

MK-677 increases anabolic capacity, but without resistance training, gains manifest primarily as body weight increase (more fat and lean mass accumulation) without structural strength development. Exercise is essential to direct MK-677 effects toward muscle growth rather than generalized weight gain.

Is MK-677 detectable in drug tests?

MK-677 is not screened in standard sports anti-doping tests (though some sports organizations are developing detection methods). However, if GH is tested (isoform testing), MK-677 may indirectly elevate GH above threshold levels, potentially flagging positive results in sports with GH testing protocols.

MK-677 Blood Sugar Concerns: Diabetes and Glucose Metabolism